loading

Carisma Therapeutics Inc Stock (CARM) Latest News

pulisher
Nov 27, 2024

Carisma Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference - PR Newswire

Nov 27, 2024
pulisher
Nov 25, 2024

Carisma Therapeutics stock target cut, maintains buy on clinical trial - Investing.com

Nov 25, 2024
pulisher
Nov 25, 2024

Carisma Therapeutics price target lowered to $5 from $8 at H.C. Wainwright - TipRanks

Nov 25, 2024
pulisher
Nov 22, 2024

Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CA - GuruFocus.com

Nov 22, 2024
pulisher
Nov 22, 2024

Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - GuruFocus.com

Nov 22, 2024
pulisher
Nov 20, 2024

Carisma Therapeutics Reports Q3 2024 Results, Advances Clinical Programs - MSN

Nov 20, 2024
pulisher
Nov 17, 2024

Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting® 2024 - PR Newswire

Nov 17, 2024
pulisher
Nov 12, 2024

Carisma Therapeutics stock a buy at D. Boral Capital, HER2 & platform value in focus - Investing.com India

Nov 12, 2024
pulisher
Nov 11, 2024

Carisma Therapeutics and Moderna Unveil Promising Pre-Clinical Data for Anti-GPC3 CAR-M Therapy - MSN

Nov 11, 2024
pulisher
Nov 10, 2024

Carisma Therapeutics Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St

Nov 10, 2024
pulisher
Nov 08, 2024

Carisma reports progress in liver cancer therapy development - Investing.com India

Nov 08, 2024
pulisher
Nov 08, 2024

Carisma reports progress in liver cancer therapy development By Investing.com - Investing.com Australia

Nov 08, 2024
pulisher
Nov 08, 2024

Carisma Therapeutics Inc. Unveils Promising Pre-Clinical Data on Anti-Gpc3 in Vivo Car-M Therapy for Hepatocellular Carcinoma - Marketscreener.com

Nov 08, 2024
pulisher
Nov 08, 2024

Carisma Therapeutics reports data from its CAR-M therapy - TipRanks

Nov 08, 2024
pulisher
Nov 08, 2024

Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma - PR Newswire

Nov 08, 2024
pulisher
Nov 07, 2024

Carisma Therapeutics reports Q3 EPS (31c), consensus (26c) - TipRanks

Nov 07, 2024
pulisher
Nov 07, 2024

Carisma Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

CARISMA Therapeutics Inc Reports Q3 2024 Revenue of $3.39M and G - GuruFocus.com

Nov 07, 2024
pulisher
Nov 05, 2024

Carisma Therapeutics Welcomes Sohanya Cheng to Board of Directors - MSN

Nov 05, 2024
pulisher
Nov 05, 2024

Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024 - Citizentribune

Nov 05, 2024
pulisher
Nov 05, 2024

Carisma to present new data on CAR-M therapy for hepatocellular carcinoma - TipRanks

Nov 05, 2024
pulisher
Nov 02, 2024

Carisma Therapeutics (NASDAQ:CARM) Upgraded at EF Hutton Acquisition Co. I - Defense World

Nov 02, 2024
pulisher
Oct 31, 2024

Carisma shares climb on EF Hutton Buy rating - Investing.com India

Oct 31, 2024
pulisher
Oct 30, 2024

Carisma Therapeutics Appoints Sohanya Cheng to Board of Directors - citybiz

Oct 30, 2024
pulisher
Oct 30, 2024

Carisma Therapeutics names Sohanya Cheng to board - Investing.com India

Oct 30, 2024
pulisher
Oct 30, 2024

Carisma Therapeutics Announces Changes to its Board of Directors - Quantisnow

Oct 30, 2024
pulisher
Oct 28, 2024

Carisma Therapeutics Reports Second Quarter 2024 Financial Resul - GuruFocus.com

Oct 28, 2024
pulisher
Oct 14, 2024

Carisma Therapeutics faces Nasdaq delisting over market value By Investing.com - Investing.com Australia

Oct 14, 2024
pulisher
Oct 14, 2024

Carisma Therapeutics faces Nasdaq delisting over market value - Investing.com

Oct 14, 2024
pulisher
Oct 11, 2024

Carisma Therapeutics to Showcase Cutting-Edge Cancer Research at SITC 2024 - MSN

Oct 11, 2024
pulisher
Oct 04, 2024

Carisma Therapeutics Announces Upcoming Presentations at SITC 2024 - Yahoo Finance

Oct 04, 2024
pulisher
Sep 24, 2024

Carly Rae Jepsen is engaged! Canadian singer shares happy news on social media: 'Very engaged over here' - Yahoo Canada Shine On

Sep 24, 2024
pulisher
Sep 24, 2024

Carly Rae Jepsen Flaunts Blue Engagement Ring with Grammy Winning Fiancé - 2paragraphs Buzz

Sep 24, 2024
pulisher
Sep 24, 2024

CRDF (Cardiff Oncology Inc) has impressive results - US Post News

Sep 24, 2024
pulisher
Sep 24, 2024

Berkley W R Corp Sells 451,295 Shares of Cartica Acquisition Corp (NASDAQ:CITE) - MarketBeat

Sep 24, 2024
pulisher
Sep 23, 2024

Carly Rae Jepsen is a fiancée! Singer announces engagement to Grammy-winning producer - USA TODAY

Sep 23, 2024
pulisher
Sep 23, 2024

Carly Rae Jepsen Engaged to Producer Cole MGN: See Her RingE! Online - E! NEWS

Sep 23, 2024
pulisher
Sep 23, 2024

'Very engaged over here': Singer Carly Rae Jepsen announces her engagement to music producer Cole M.G.N. - 9Honey Celebrity

Sep 23, 2024
pulisher
Sep 23, 2024

Investing in Aclaris Therapeutics Inc (ACRS) Is Getting More Attractive - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Surprise! Carly Rae Jepsen Is Engaged!!! - PerezHilton.com

Sep 23, 2024
pulisher
Sep 23, 2024

Nasdaq-Traded Cannabinoid Biotech Corbus Pharma Stock Plunges 60%, But Analysts Say 'Buy The Dip' Now - Benzinga

Sep 23, 2024
pulisher
Sep 23, 2024

Carly Rae Jepsen announces engagement to boyfriend Cole MGN after two years of dating - Daily Mail

Sep 23, 2024
pulisher
Sep 23, 2024

Carly Rae Jepsen Proclaims Herself ‘Very Engaged Over Here’ in Photoshoot Showing Off Ring From Fiancé Cole M.G.N. - Billboard

Sep 23, 2024
pulisher
Sep 23, 2024

Carly Rae Jepsen Engaged to Producer Cole M.G.N. - AceShowbiz Media

Sep 23, 2024
pulisher
Sep 23, 2024

Carly Rae Jepsen & Boyfriend Cole M.G.N. Are Engaged! - Just Jared

Sep 23, 2024
pulisher
Sep 23, 2024

Cole M.G.N. Entertainment News, Photos, and Videos - Just Jared

Sep 23, 2024
pulisher
Sep 23, 2024

A closer look at Cara Therapeutics Inc (CARA) is warranted - US Post News

Sep 23, 2024
pulisher
Sep 23, 2024

Hancock Whitney Corp Has $737,000 Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World

Sep 23, 2024
$18.94
price down icon 1.35%
$75.45
price up icon 0.87%
$43.39
price up icon 3.19%
$378.13
price up icon 0.30%
$206.16
price up icon 7.31%
$120.72
price up icon 1.84%
Cap:     |  Volume (24h):